Be sure to check our sister interview main ratings news website

AVCT

Hardman & Co

Avacta Group Plc Wake-up call for the market

10th December 2018

Avacta Group Plc (LON: AVCT) is a pre-clinical stage biotechnology company and the proprietary owner of Affimer technology. Affimers represent a radical alternative to the established antibody technology. The significant

Hardman & Co

Avacta In vivo expression of Affimers

31st May 2018

Avacta Plc (LON:AVCT) is a pre-clinical biotechnology company and the proprietary owner of Affimer technology. Affimers represent a radical alternative to the established antibody technology, which continues to dominate the

Hardman & Co

Avacta Group Affimer Drug Conjugates a reality

15th January 2018

Avacta Group Plc (LON:AVCT) is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody technology

Hardman & Co

Avacta Group R&D accelerated to advance assets

16th October 2017

Avacta Group Plc (LON:AVCT) is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody technology

Hardman & Co

Avacta Group Plc Another important box ticked

12th April 2017

Avacta Group Plc (LON:AVCT) is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody technology

Hardman & Co

Avacta Group Plc Low response would be positive!

21st March 2017

Avacta Group Plc (LON:AVCT) is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody technology

Hardman & Co

Avacta Group Plc Great strides towards strategic goals

18th October 2016

Avacta Group Plc (LON:AVCT) is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a revolutionary alternative to the established antibody

Q&As

Diversified Energy Company plc

Diversified Energy Company: Maverick acquisition, growth strategy and sustainability goals (LON:DEC)

Diversified Energy CEO Rusty Hutson discusses the Maverick Natural Resources acquisition and its impact on growth, margins, and sustainability goals.
Cerillion

Cerillion CEO on $11.4m telecoms deal and growth strategy (LON:CER)

In an exclusive interview with DirectorsTalk, Cerillion plc CEO Louis Hall discusses the $11.4 million telecom contract and its impact on the company's growth strategy.
Pan African Resources

Pan African Resources well-placed for future on extraordinary low PE ratio says fund manager (LON:PAF)

Discover the success behind Pan African Resources plc and its outperformance as discussed by Gervais Williams, Co-Fund Manager of Diverse Income Trust plc.
One Health Group plc

One Health Group CEO on Financial Growth and NHS Collaborations (AQSE:OHGR)

In an exclusive interview, One Health Group plc CEO Adam Binns discusses the company's partnership with the NHS, operational growth, and future plans.
Ilika plc

Ilika: Pioneering Solid-State Battery Advancements (LON:IKA)

In an exclusive interview, Ilika plc CEO Graeme Purdy discusses progress with Stereax & Goliath, exciting technical milestones, and competition with peers.
Arbuthnot Banking Group plc

Arbuthnot Banking has better opportunities and upside than NatWest Bank says Gervais Williams (LON:ARBB)

Gervais Williams discusses Arbuthnot Banking Group plc's success and potential growth in an exclusive interview with DirectorsTalk.

Funds

Fidelity Emerging Markets

Emerging Markets equities unlock growth potential for investors

Explore the potential of emerging markets equities for growth and diversification. Learn how active management strategies can maximize returns and navigate market dynamics.
Team plc

Market volatility amid tariff threats and economic uncertainty

Last week’s Wall Street volatility, fueled by tariff threats and tech struggles, raised investor concerns. Economic uncertainty looms with conflicting data.
Fidelity China Special Situations

Chinese tech stocks surge as AI innovations spark investor confidence

Chinese and Hong Kong tech stocks surge as AI startup DeepSeek's breakthrough model ignites investor confidence in China's AI prowess.
Fidelity Japan Trust

Japan’s AI market transformed by DeepSeek’s breakthrough

Fidelity European Trust

European Markets on a high note, defying tariff tensions

European stock markets soar as BP shines amid fresh US tariff threats. Investors navigate opportunity and risk amid trade policy shifts and corporate shakeups.
Fidelity Special Values

Investors brush off tariff threats as markets hold steady

Global markets steady despite Trump tariff threats. FTSE 100 up as investors weigh impact of import tax. BP surges after activist stake.

Presentations

Challenger Energy

Challenger Energy plc Transforming Exploration Potential into a Frontier Opportunity

Discover Challenger Energy Group's visionary approach to exploration in Uruguay and strategic partnerships with Chevron in this detailed presentation by CEO Eytan Uliel. High-growth potential for investors.
Cerillion

Cerillion PLC Annual Results 2024 ‘Record Highs’, Louis Hall CEO

Norcros Plc

Norcros Plc CEO and CFO Present Interim Results to 30 September 2024 (LON:NXR)

Ilika plc

Ilika plc: A New Era in Solid-State Battery Innovation – 2024 Investor Presentation

Time Finance plc

Time Finance PLC Strong Growth and Strategic Progress: A Message from CEO Ed Rimmer

Pulsar Helium Inc

Pulsar Helium Inc.: A Pioneering Force in the Helium Industry with High-Concentration Discoveries

Broker Talk

Beeks Financial Cloud Group Plc: Leading the Way with Nasdaq Partnership – Canaccord Genuity

Beeks Financial Cloud Group Plc secures Nasdaq as the latest customer for its Exchange Cloud service, solidifying its leadership in low-latency solutions.

Agronomics: Unlocking the Future of Cellular Agriculture – Cavendish

Agronomics Limited (LON:ANIC) shapes the future of sustainable food production with strategic investments in cellular agriculture. Cavendish report highlights its progress in 2024.

SAE Renewables Limited Receives Final Payment for Uskmouth BESS Project – Zeus Capital

SAE Renewables (LON:SAE) advances energy ambitions with £1.3M payment for Uskmouth BESS project. Analyst sees positive impact on future projects.
hVIVO plc

hVIVO Secures Landmark £3.2 Million Contract: Cavendish

hVIVO plc achieves milestone with £3.2 million hLAB contract, showcasing growth in laboratory services. Read about the company's latest achievement here.
Ilika plc

Ilika Plc Stereax Production Milestone Signals a Bright Future – Cavendish

Greggs

Greggs Demonstrates Resilience Amid Challenging Market Conditions – Edison Investment Research

Greggs plc (LON:GRG) shines in tough market conditions, delivering solid FY24 results with revenue of £2,014 million and strong growth.

© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.